Xiaolong Xu
South China Agricultural University(CN)Zhejiang Chinese Medical University(CN)Central South University(CN)Jinan University(CN)Beijing University of Chinese Medicine(CN)Capital Medical University(CN)Sichuan University(CN)Southern University of Science and Technology(CN)Guangzhou Sport University(CN)Nanjing University of Posts and Telecommunications(CN)Key Laboratory of Guangdong Province(CN)Jiangsu Agri-animal Husbandry Vocational College(CN)Nanfang Hospital(CN)Chinese Academy of Agricultural Sciences(CN)Southern Medical University Shenzhen Hospital(CN)Institute of Environment and Sustainable Development in Agriculture(CN)Beijing Hospital of Traditional Chinese Medicine(CN)Xiangya Hospital Central South University(CN)Shenzhen Second People's Hospital(CN)State Key Laboratory of BiotherapySouthern Medical University(CN)
Publications by Year
Research Areas
Gut microbiota and health, Autophagy in Disease and Therapy, COVID-19 Clinical Research Studies, Acupuncture Treatment Research Studies, Pediatric health and respiratory diseases
Most-Cited Works
- → Osteoclast-derived microRNA-containing exosomes selectively inhibit osteoblast activity(2016)298 cited
- → miR-214 promotes osteoclastogenesis by targeting Pten/PI3k/Akt pathway(2015)227 cited
- → Punicalagin Inhibits Inflammation in LPS-Induced RAW264.7 Macrophages via the Suppression of TLR4-Mediated MAPKs and NF-κB Activation(2014)167 cited
- → Punicalagin Induces Nrf2/HO‐1 Expression via Upregulation of PI3K/AKT Pathway and Inhibits LPS‐Induced Oxidative Stress in RAW264.7 Macrophages(2015)144 cited
- → Regulation of phosphoribosyl ubiquitination by a calmodulin-dependent glutamylase(2019)129 cited
- → Development of potent and selective inhibitors targeting the papain-like protease of SARS-CoV-2(2021)100 cited